Next Article in Journal
In Vivo Analysis of Protein–Protein Interactions with Bioluminescence Resonance Energy Transfer (BRET): Progress and Prospects
Next Article in Special Issue
Clinical Decision-Making in the Treatment of Schizophrenia: Focus on Long-Acting Injectable Antipsychotics
Previous Article in Journal
T Cell Receptor Excision Circle (TREC) Monitoring after Allogeneic Stem Cell Transplantation; a Predictive Marker for Complications and Clinical Outcome
Previous Article in Special Issue
Prevalence and Predictors of Clozapine-Associated Constipation: A Systematic Review and Meta-Analysis
Article Menu
Issue 10 (October) cover image

Export Article

Open AccessReview
Int. J. Mol. Sci. 2016, 17(10), 1700; doi:10.3390/ijms17101700

Do Atypical Antipsychotics Have Antisuicidal Effects? A Hypothesis-Generating Overview

1
Department of Neurosciences, Mental Health and Sensory Organs, Suicide Prevention Center, Sant’Andrea Hospital, Sapienza University of Rome, Rome 00189, Italy
2
International Consortium for Mood and Psychotic Disorders Research, Mailman Research Center, McLean Hospital, Belmont, MA 02468, USA
3
Department of Psychiatry, Harvard Medical School, Boston, MA 02115, USA
4
Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, Section of Psychiatry, University of Genoa, Genoa 16126, Italy
5
Department of Psychiatry, University of Naples SUN, Naples I-80138, Italy
*
Author to whom correspondence should be addressed.
Academic Editors: Domenico De Berardis and Michele Fornaro
Received: 21 July 2016 / Revised: 19 September 2016 / Accepted: 22 September 2016 / Published: 11 October 2016
(This article belongs to the Special Issue Antipsychotics)
View Full-Text   |   Download PDF [236 KB, uploaded 11 October 2016]

Abstract

Modern antipsychotic drugs are employed increasingly in the treatment of mood disorders as well as psychoses, stimulating interest in their possible contributions to altering suicidal risk. Clozapine remains the only treatment with an FDA-recognized indication for reducing suicidal risk (in schizophrenia). We carried out a systematic, computerized search for reports of studies involving antipsychotic drug treatment and suicidal behaviors. A total of 19 reports provide data with preliminary support for potential suicide risk-reducing effects of olanzapine, quetiapine, ziprasidone, aripiprazole, and asenapine in addition to clozapine, and provide some support for antipsychotic drug treatment in general. These preliminary findings encourage further testing of antipsychotics for effects on suicidal behavior, making use of explicit, pre-planned assessments of suicidal behavior. View Full-Text
Keywords: antipsychotic; aripiprazole; asenapine; atypical; clozapine; olanzapine; quetiapine; risperidone; second-generation; suicide; ziprasidone antipsychotic; aripiprazole; asenapine; atypical; clozapine; olanzapine; quetiapine; risperidone; second-generation; suicide; ziprasidone
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Pompili, M.; Baldessarini, R.J.; Forte, A.; Erbuto, D.; Serafini, G.; Fiorillo, A.; Amore, M.; Girardi, P. Do Atypical Antipsychotics Have Antisuicidal Effects? A Hypothesis-Generating Overview. Int. J. Mol. Sci. 2016, 17, 1700.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top